HEXIM1 was proposed as a mediator of HMBA actions in cancer cells (He et al, 2006; Turano et al, 2006; Yoshikawa et al, 2012; Ketchart et al, 2013, 2016; Lama et al, 2017). This evidence concerns the gene HEXIM1 and cancer.